Abstract:OBJECTIVE:To investigate the effects of lentivirus mediated siRNA targeting human metastasis suppressor 1 (MTSS1, MIM-B gene) gene on the invasive and metastatic potentials of hepatocellular carcinoma (HCC) MHCC97H cells.METHODS:The siRNA targeting MTSS1 was cloned into one lentivirus work vector. The work vector and three package plasmids were co-transfected into 293T cells with the help of lipefeetamine 2000. Lentivirus was collected in 72 hours and was added to the cultured MHCC97H cells. The total cell MIM-B mRNA and MIM-B protein were extracted and underwent real-time PCR and western-blot test respectively. Boden chamber assay was used to evaluate the invasive potential of MHCC97H cells. Gelatin zymography was used to detect matrix metalloproteinase-2 (MMP2) activity. Metastatic human HCC nude mice models were established by orthotopic implantation with a high metastatic potential human HCC cell line MHCC97H. Twenty-four nude mice bearing orthotopic xenografts were randomized into black control group, Lenti-GFP group and intervention group (Lenti-MTSS1 group) 14 days after orthotopic implantation (8 per group). The ultrasound-guided multi-point injection was performed on mice with borate buffered saline, Lenti-GFP and Lenti-MTSS1 respectively. Mice were sacrificed on day 35 for the examination of pulmonary metastasis. The SPSS 13.0 soft ware was applied to data analysis.RESULTS:The small interfering RNA targeting MTSS1 was constructed successfully with a transfection efficiency of 97.0%, which produced a marked inhibition of invasive ability of MHCC97H cells through Matrigel, being 37.9+/-4.4, 37.4+/-5.3 and 26.6+/-4.6 in the black control group, Lenti-GFP group and Lenti-MTSS1 group (F = 26.695, P value is less than 0.01), respectively. MIM-B expression and MMP2 activity of intervention group were also significantly down-regulated as compared to the control group. The results of in vivo studies showed that the numbers of lung metastatic nodules were 6.5+/-2.6, 6.4+/-2.7 and 3.8+/-1.3 in the black control group, Lenti-GFP group and intervention group respectively with significant statistical difference (F = 3.637, P value is less than 0.05), accorded with tumor tissue MIM-B mRNA expression of 0.39+/-0.19, 0.38+/-0.10 and 0.16+/-0.11 respectively (F = 11.644, P value is less than 0.01) when comparison was made between control group and therapy group.CONCLUSION:Small interfering RNA mediated by lentivirus inhibited MIM-B expression and resulted in inhibition of the invasive and metastatic potentials of MHCC97H cells, which may attributed, in part, the down regulation of MMP2 activity, and thus may provide a new molecular targeted therapy for HCC patients in the future.

In Vitro Inhibitory Effect of Sorafenib on Proliferation of Human Hepatocellular Carcinoma Cells with Differential Perk Expression Reinforced by Lentivirus-Mediated Small RNA Interference Targeting MIM-B Gene

siRNA-mediated silencing of BC047440 gene inhibits proliferation of human HepG2 cell

[Effects of MIM-B Gene on Invasive and Metastatic Potentials of Human Hepatocellular Carcinoma MHCC97H Cells].

Phosphorylated ERK is a Potential Prognostic Biomarker for Sorafenib Response in Hepatocellular Carcinoma.

[Anticancer Effect of SN-38 Combined with Sorafenib on Hepatocellular Carcinoma in Vitro and Its Mechanism].

The Mir-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis Through Altering the Androgen Receptor Signals

Suppression of the expression of multidrug resistance protein in liver cancer cells by sorafenib and the growth of subcutaneous tumor in nude mice model treated by a combination of sorafenib and fluorouracil

Inhibition of the Wnt/β-catenin Signaling Pathway Improves the Anti-Tumor Effects of Sorafenib Against Hepatocellular Carcinoma.

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint.

An Investigation of the Effect of Sorafenib on Tumour Growth and Recurrence after Liver Cancer Resection in Nude Mice Independent of Phosphorylated Extracellular Signal-Regulated Kinase Levels

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma

[Suppression of the Growth of Subcutaneous Transplanted Human Liver Cancer and Lung Metastasis in Nude Mice Treated by Sorafenib Combined with Fluorouracil].

[Inhibitory Effect of Lentiviral Vectors Expressing Small Interfering RNA Targeting Survivin Gene on Hep-2 Cell Growth in Vitro and in Nude Mice].

Synergistic Anti-Hepatoma Effect of Bufalin Combined with Sorafenib Via Mediating the Tumor Vascular Microenvironment by Targeting Mtor/vegf Signaling

Anti-proliferation effect of sorafenib in combination with 5-FU for hepatocellular carcinoma in vitro: antagonistic performance and mechanism

Analysis Of Signal Pathway Activation In Hepatocellular Carcinoma: Association With Clinical Outcomes To Sorafenib In Chinese Patients

Experimental Research on the Inhibitory Effect of IFN-Lambda 3 Combined with Sorafenib on the Growth of Liver Cancer Transplanted into Nude Mice

Sorafenib Inhibits Proliferation and Invasion of Human Hepatocellular Carcinoma Cells Via Up-Regulation of P53 and Suppressing FoxM1

Metformin Sensitizes Sorafenib to Inhibit Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma in Orthotopic Mouse Models

Proteome Analysis of the Effects of Sorafenib on Human Hepatocellular Carcinoma Cell Line Hepg2